Please login to the form below

Not currently logged in
Email:
Password:

Aerospan

This page shows the latest Aerospan news and features for those working in and with pharma, biotech and healthcare.

Mylan raises offer for Meda to $9bn

Mylan raises offer for Meda to $9bn

Also due to launch shortly is Aerospan (flunisolide), an inhaler therapy for asthma - incorporating a spacer to improve drug delivery to the lungs - that Meda has said could achieve sales of

Latest news

  • Meda buys US respiratory firm Acton in $200m deal Meda buys US respiratory firm Acton in $200m deal

    Swedish pharma firm gains access to asthma treatment Aerospan. Swedish pharma company Meda has agreed to buy US company Acton in a deal that gives it a ready-to-launch asthma ... product. Meda is paying $125m upfront for Acton, which has been sitting on

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

DNA
Why precision medicine demands precision engagement
The speed of innovation brings its own challenges, says cloud computing expert...
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...

Infographics